As per our analysis report, the global ventilator market is estimated to be worth USD 10.08 billion in 2029, growing at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2029.
The burden of respiratory diseases is rising due to various causes, such as smoking, obesity, and behavioral changes. Also, lung and respiratory disorders, such as chronic obstructive pulmonary disease (COPD) and bronchial asthma, consistently need ventilators as they cause postoperative problems among patients. The increasing incidence of these target indications raises the affected patient's hospital admission and readmitted rates as they may need regular ventilation assistance. Besides, with an uptick in the aging population, there has been a corresponding increase in cardiovascular disease, stroke, and diabetes. The need for prompt medical attention distinguishes these cases.
The ventilation system gives artificial or mechanical respiration to a patient suffering from some chronic condition. Also, growing people's discretionary incomes and their ability to pay more for specialized healthcare systems have facilitated the development and upgrading of healthcare infrastructure and treatment facilities. As a result, it also brings momentum to the market. Technological developments, growing healthcare costs, and an increasing number of intensive care beds in developing markets also drive the development of the global ventilator industry. The industry is similarly influenced by a high rate of premature births, rising demand for medical care in the senior community, and government efforts to improve the development of ventilators. However, the shortage of qualified healthcare personnel, the lack of consistent terminology for various ventilation types, and the high costs associated would significantly restrict business development.
Technological advancements in microprocessor-controlled ventilation, integrated with the challenge of new ventilation types, have created a multidisciplinary healthcare team with a range of ways to transform critically ill ventilation treatment for patients. Advanced ventilators are ready for all specifications and have multiple checks and balances. Patient-specific parameters such as air pressure, air volume, and flow rate, and general parameters such as air leakage, mechanical loss, power failure, battery replacement, oxygen tanks, and remote control are fitted with sensors and monitors.
Factors such as preterm birth, rapid growth in population, rising lung diseases, and an increased number of ICU beds are promoting the ventilator market growth worldwide. The growth in chronic illness among children and the diseases related to hearts and lungs due to lifestyle changes have also increased the demand for ventilators. The growth in the number of home therapists has also led to an increase in demand for ventilators. Countries like India, China, and Brazil have led a rise in the need for ventilators in these countries. These countries have increased their healthcare budgets, and there is a significant share of the development of ventilators in these budgets.
The ventilators are very complex to use, and only trained professionals should be allowed to use them; due to the lack of such professionals worldwide, ventilators are restricted. Physicians have also shown a lack of transition to ventilators, which can be challenging. Ventilator costs are high worldwide, making them inaccessible to the poor, thus limited in reach. The improper functioning of alarms, inappropriate heating or humidification of the inspired gas, and improper ventilation cycle are minor complications during ventilation.
The COVID-19 virus is spreading around the world. With the increase in coronavirus cases, there is also an increase in demand for ventilators worldwide, which will drive the growth. Many countries like India, which have a large population with a high population density, are severely affected by the virus. Due to the large population, the current ventilator number is insufficient to cater to needs; thus, India is importing ventilators from other countries, leading to new business establishments in the ventilator market. In addition, countries like the USA and France face ventilator shortages due to rising coronavirus cases and have started spending more on ventilators than before. It has motivated new players to make low-cost and efficient ventilators to meet high demand, which can be supplied even to low or not-so-resourceful countries.
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2023 to 2029 |
|
Base Year |
2023 |
|
Forecast Period |
2024 to 2029 |
|
Segments Covered |
By Type Of Interface, End-Users, Mobility, And Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter's Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
|
Market Leader Profiled |
Philips, Resmed, Medtronic, Becton, Dickinson and Company, Getinge, Dräger, Smiths Group, Hamilton Medical, G.E. Healthcare, Fisher & Paykel, Air Liquide, Asahi Kasei, and Allied Healthcare Products |
The invasive segment led the ventilator market in 2023 and is expected to register a prominent CAGR during the forecast period. Mechanical ventilation is termed Invasive Ventilation. Invasive ventilatory support is provided via either an endotracheal tube or a tracheostomy tube. Wide applications in respiratory diseases, neurological diseases, and sleeping disorders are the primary factors supporting the growth of the invasive ventilation segment.
The non-invasive ventilation segment accounted for a considerable share of the worldwide market in 2023 and is predicted to witness a healthy CAGR during the forecast period. Non-invasive ventilation is the one where support is not provided via the endotracheal tube or tracheostomy tube. Non-invasive ventilation is breathing support through a face mask or nasal mask. Air pressure is administered depending on whether the person is breathing in or out. NIV is used due to the reason that it can avoid spreading the infection. It is second in market share and is expected to increase rapidly.
The hospitals and clinics segment occupied the major share of the worldwide market in 2023 and is predicted to continue to be the dominating segment in the global market throughout the forecast period. Hospitals and clinics are the largest end-users of ventilators because ventilators are expensive and difficult to procure. However, especially during COVID-19 times, hospitals have increased their inventory of ventilators to cure patients with severe conditions.
The home care segment is the second-largest ventilator market and is expected to register the highest CAGR. The increased awareness of ventilator technology among patients and doctors and increased healthcare budgets by personnel have driven this segment's growth.
Ambulances are the third largest but are expected to rise at a reasonable growth rate due to increased budgets for quality healthcare from private and public institutions.
Emergency medical services are also expected to have a reasonable growth rate due to increased emergency medical cases.
The intensive-care segment is expected to hold the leading share of the global ventilator market during the forecast period. Intensive-care ventilators have the largest market share and are expected to increase as more hospitals and other healthcare institutions are built.
Although they are second in market share, portable ventilators are expected to have a promising CAGR. Portable ventilators are used in cases where ambulances and home care are needed.
North American had the largest share in the global ventilator market in 2023, as the quality of health facilities is much better than in other countries. The hospitals are more advanced, and the significant players in the ventilator market see massive potential and invest more in research and development.
Europe had the second-largest share worldwide in 2023, as the government allocated a fair share for the healthcare industry in its budget. Increased smoking, a rising population, and high healthcare expenditure drive market growth.
Asia-Pacific had the third-largest share in the global market in 2023. It is expected to grow at a reasonable rate due to the increase in population in China and India. Also, the healthcare budgets and facilities are significantly less compared to the North American and European markets.
During the forecast period, the Latin American market is anticipated to grow at a steady CAGR.
The MEA market is estimated to grow at a moderate share of the worldwide market in the coming years.
Companies such as Philips, Resmed, Medtronic, Becton, Dickinson and Company, Getinge, Dräger, Smiths Group, Hamilton Medical, G.E. Healthcare, Fisher & Paykel, Air Liquide, Asahi Kasei, and Allied Healthcare Products are expected to account for the majority of the global ventilators market share during the forecast period.
By Type of Interface
By End-users
By Mobility
By Region
Frequently Asked Questions
Based on the mobility, the intensive care ventilators segment led the global ventilators market in 2023 and is projected to continue showing dominance throughout the forecast period.
The global ventilator market size is predicted to be USD 9.05 billion in 2028.
Philips, Resmed, Medtronic, Becton, Dickinson and Company, Getinge, Dräger, Smiths Group, Hamilton Medical, GE Healthcare, Fisher & Paykel, Air Liquide, Asahi Kasei, and Allied Healthcare Products are some of the leading manufacturers of ventilators in the market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1800
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region